APA (7th ed.) Citation

Kim, W. Y., Whang, Y. E., Pruthi, R. S., Baggstrom, M. Q., Rathmell, W. K., Rosenman, J. G., . . . Godley, P. A. (2011). Neoadjuvant docetaxel/estramustine prior to radical prostatectomy or external beam radiotherapy in high risk localized prostate cancer: A phase II trial. Urologic oncology, 29(6), 608-613. https://doi.org/10.1016/j.urolonc.2009.09.012

Chicago Style (17th ed.) Citation

Kim, William Y., et al. "Neoadjuvant Docetaxel/estramustine Prior to Radical Prostatectomy or External Beam Radiotherapy in High Risk Localized Prostate Cancer: A Phase II Trial." Urologic Oncology 29, no. 6 (2011): 608-613. https://doi.org/10.1016/j.urolonc.2009.09.012.

MLA (9th ed.) Citation

Kim, William Y., et al. "Neoadjuvant Docetaxel/estramustine Prior to Radical Prostatectomy or External Beam Radiotherapy in High Risk Localized Prostate Cancer: A Phase II Trial." Urologic Oncology, vol. 29, no. 6, 2011, pp. 608-613, https://doi.org/10.1016/j.urolonc.2009.09.012.